Cas:887592-04-3 ethyl 4-bromo-2-methylbenzenecarboximidate manufacturer & supplier

Chemical Name:ethyl 4-bromo-2-methylbenzenecarboximidate

CAS.NO:887592-04-3

Synonyms:Benzenecarboximidicacid,4-bromo-2-methyl-,ethyl ester;4-BROMO-2-METHYL-BENZIMIDIC ACID ETHYL ESTER

Molecular Formula:C₁₀H₁₂BrNO

Molecular Weight:242.11200

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:N/A

Density:N/A

Index of Refraction:

PSA:33.08000

Exact Mass:241.01000

LogP:3.21910

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like Benzenecarboximidicacid,4-bromo-2-methyl-,ethyl ester chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,4-BROMO-2-METHYL-BENZIMIDIC ACID ETHYL ESTER physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Benzenecarboximidicacid,4-bromo-2-methyl-,ethyl ester Use and application,4-BROMO-2-METHYL-BENZIMIDIC ACID ETHYL ESTER technical grade,usp/ep/jp grade.

Related News: Resonant exploits its proprietary IMPaCT tumor microenvironment models and data platform to discover novel, unappreciated targets and functionally active anti-tumor antibodies for difficult to treat tumors. ethyl 4-bromo-2-methylbenzenecarboximidate manufacturer Beta Bionics is pursuing regulatory approval of its insulin-only bionic pancreas, followed by its dual-hormone system, which will also administer a glucagon analog in order to raise blood-sugar levels without the need to consume carbohydrates. Beta Bionics operates in Massachusetts and California. ethyl 4-bromo-2-methylbenzenecarboximidate supplier Resonant exploits its proprietary IMPaCT tumor microenvironment models and data platform to discover novel, unappreciated targets and functionally active anti-tumor antibodies for difficult to treat tumors. ethyl 4-bromo-2-methylbenzenecarboximidate vendor It does not require a production license for the drug substance, and can be produced in an ordinary chemical plant. As long as it reaches a certain level, it can be used for the synthesis of the drug substance. ethyl 4-bromo-2-methylbenzenecarboximidate factory Fate Therapeutics is a clinical-stage biopharmaceutical company dedicated to the development of first-in-class cellular immunotherapies for cancer and immune disorders.